论文信息 - Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open‐Label, Active‐Treatment Extension Study - 字舞流文

Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open‐Label, Active‐Treatment Extension Study

C. Wouters | N. Wulffraat | E. Alexeeva | R. Schneider | I. Tirosh | V. Chasnyk | A. Martini | J. Levy | P. Quartier | E. Vritzali | H. Brunner | B. Lauwerys | T. Constantin | D. Lovell | I. Koné-Paut | J. Kuemmerle-Deschner | N. Ruperto | M. Trachana | T. Kallinich | O. Vougiouka | I. Nikishina | K. Marzan